Table 1 Genotype and allele analysis of 34 SNPs among 221 individuals with PD.
Total (n = 221) | SN+ (n = 122) | SN− (n = 99) | OR | 95% CI | P | |
|---|---|---|---|---|---|---|
Gender (Male, %) | 138 (62.4%) | 92 (75.4%) | 46 (46.5%) | 0.32 | 0.16–0.63 | 0.001* |
Age (years) | 62.5 ± 8.6 | 63.4 ± 8.2 | 61.4 ± 9.0 | 1.02 | 0.98–1.06 | 0.260* |
PD Duration (years) | 4.3 ± 3.6 | 4.3 ± 3.8 | 4.2 ± 3.2 | 1.01 | 0.91–1.13 | 0.833* |
H-Y | 2.1 ± 0.7 | 2.1 ± 0.7 | 2.1 ± 0.8 | 0.78 | 0.42–1.46 | 0.432* |
UPDRS-III | 25.0 ± 11.9 | 25.6 ± 12.7 | 24.4 ± 10.9 | 1.01 | 0.97–1.05 | 0.552* |
rs731821 (CC/CA/AA) | 122/87/12 | 75/44/3 | 47/43/9 | 0.45 | 0.24–0.86 | 0.016* |
rs3737084 (CC/CG/GG) | 132/74/15 | 62/49/11 | 70/25/4 | 2.07 | 1.17–3.67 | 0.013* |
Gender (Male, %) | 276 (62.4%) | 184 (75.4%) | 92 (46.5%) | 0.31 | 0.20–0.49 | <0.001† |
Age (years) | 62.5 ± 8.6 | 63.4 ± 8.2 | 61.4 ± 9.0 | 1.02 | 0.99–1.05 | 0.139† |
PD Duration (years) | 4.3 ± 3.5 | 4.3 ± 3.8 | 4.2 ± 3.2 | 1.01 | 0.94–1.09 | 0.791† |
H-Y | 2.1 ± 0.7 | 2.1 ± 0.7 | 2.1 ± 0.7 | 0.79 | 0.53–1.19 | 0.264† |
UPDRS-III | 25.0 ± 11.9 | 25.6 ± 12.7 | 24.4 ± 10.9 | 1.01 | 0.99–1.04 | 0.293† |
rs731821 (C/A) | 331/111 | 194/50 | 137/61 | 0.44 | 0.24–0.83 | 0.011† |
rs3737084 (C/G) | 338/104 | 173/71 | 165/33 | 2.51 | 1.39–4.53 | 0.002† |